Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
On a clear day you can see forever, which is it?
WallllStreetMyWay.......... since you tend to post as to information that the companies stock will explode and there is a name change on the way, would you dare try your hand at posting, that the new name change will carry the Current Stock OR will it be a New Name with a New Stock issue?
A name change carrying the current o/s of 80mil+ and a news release of another source or whatever, may dance a little for the play you seem to support, other then, it's bnvi final last farewell good-bye forever along with their great show of a bkcy.
VBR
The company pick up and went home in the start of phase 3 saying that they ran out of money and no investors... very odd?? They liquidated their assets, went bankrupt, closed down shop, but there are 2 FDA trials completed on their Menerba drug, got to worth big money somehow somewhere,possibly a company may pick up what's left in FDA past trials and research doc.any ones guess. made a few bucks on the first round...rolled it back in on this round and in the black.
JMO
Good Luck,
jury is still out...FDA doc's, got to be worth something... to somebody... somehow???
Several people I have spoken to in further due diligence have mentioned>>>Foul Play.
Here's some of what they say..
If they received approx. 50mil @ auction @ so much on the dollar what did they spend on equipment in the beginning?? what kind of money in addition did they spend setting up offices, labs, workers, salaries etc.etc etc... Then completed (Two FDA Trials with excellent results,_____ as they go into their third trial they throw up their hands and say no funding , with 2 trials under their belt and a guess of hundreds of million dollars spent on the whole project in 6 years this is horse chit at it's best.
The 50 mil they got may pay off the backers and some left over for the insiders ,,> the FDA trial documents are worth got to be something big, what are they going to do with the trial research fda doc.'s, sell them and have a funneling of side revenue, to do a fda trial got to be in the 50 of millions start to finish just for one trial ,plus all their other research on cancer drugs etc...they spent 100's upon 100's of millions of dollars then go home???
somebody got in someones ear real loud about something...
the crap never stops...just gets crappier...
On May 3rd the vote on the 250 reverse takes place cfo boyle is out...possible change up??
On April 27, 2012, J. David Boyle II resigned from his position as Senior Vice President and Chief Financial Officer of Bionovo, Inc. to pursue other business interests.
If you find out where...please post it, I'II do the same
Regards
- Proxy Statement (definitive) (DEF 14A)
Print
Alert
Big boy's vote it in, then later be awarded new shares/warrants to fatten themselves back up, all the current public holders will be destroyed...company starting all over...if your a holder vote it down, you got nothing to lose that you haven't already lost.
This company takes the award for the most disgustingly managements of all time, it should be published in 'Guinness World Records' as a model for the most unfavorable pig headed company ever conceived.
This is their 2nd reverse split in less then a year...the 1st was a 1 for 5... now a 1 for 250
case closed,
Regards
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ Preliminary Proxy Statement
¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
x Definitive Proxy Statement
¨ Definitive Additional Materials
¨ Soliciting Material Pursuant to §240.14a-12
BIONOVO, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
x No fee required.
¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
¨ Fee paid previously with preliminary materials:
¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1) Amount previously paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
To Be Held on May 3, 2012
A Special Meeting of Stockholders of Bionovo, Inc., a Delaware corporation (“Bionovo” or the “Company”), will be held at 10 a.m., local time, on May 3, 2012, at the Company’s headquarters located at 5858 Horton Street, Suite 400, Emeryville, California, for the following purposes:
>>>>>>>>>> 1. To approve an amendment to the Company’s certificate of incorporation, as amended (the “Certificate of Incorporation”), to effect a reverse stock split of our common stock at an exchange ratio of 1-for-250 (the “Amendment”), and to authorize the Board of Directors, in its discretion, to implement the reverse stock split at any time prior to December 31, 2012 by filing an amendment to the Certificate of Incorporation; and
2. To adjourn or postpone the special meeting to permit further solicitation of proxies in favor of Proposal No. 1 in the event there are insufficient votes at the time of the meeting to adopt Proposal No. 1.
The foregoing items of business are more fully described in the proxy statement accompanying this notice.
Only holders of record of our common stock at the close of business on March 23, 2012, the record date for the special meeting, are entitled to notice of and to vote at the meeting and at any adjournment or postponement thereof.
All stockholders are cordially invited to attend the meeting. To assure your representation at the meeting, however, we urge you to vote by proxy as promptly as possible over the Internet or by phone as instructed in the Notice of Internet Availability of Proxy Materials or, if you receive paper copies of the proxy materials by mail, you can also vote by mail by following the instructions on the proxy card. If you are a holder of record of our common stock on the record date, you may vote in person at the meeting even if you have previously returned a proxy.
Important Notice Regarding the Internet Availability of Proxy Materials for the Special Meeting of Stockholders to be held on May 3, 2012: We have elected to provide access to our proxy materials by: (i) sending you this full set of proxy materials, including the proxy statement and a proxy card; and (ii) notifying you of the availability of these proxy materials on the Internet that you may download and print at http://www.edocumentview.com/BNVI . We encourage you to review all of the important information contained in the proxy materials contained herein or accessed via the website before voting.
Sincerely,
/s/ Dr. Mary Tagliaferri
Mary Tagliaferri
President and Secretary
Emeryville, California
April 3, 2012
all remains to be seen...stay tuned...
You are correct sir! but the chapter 11 could hopefully be avoided , bring in a big partner offering a great deal with ice cream and cake ...
They have passed FDA phase I & II, they are into III... their manufacturing facility photo looks very operable, some of the best doctors and chemist with institutions were behind Bionovo ,
I still can't believe what has happened here.
There is to much money to be had to throw in the towel at this critical juncture, it's a billion dollar market for this hot flash drug and others.
Time will tell, maybe the new CFO got a connection for a rejuvenation to avoid the constipation.
regards
I'm one of the ones they have pulled the rug out from
and it is not comforting here...
It's time to go with the flow and see how the new cfo structures the company.
I do not see the company doing much of anything till the results come in on III, with the final towards 4th quarter but having updates periodically until then. They are working to get the III trial completed at this time, coming in on the last stretch of testing,past results so far are very promising.
...I believe they cancelled the conference call cause it would be and irritating one,they need to clean up the mess,put something on the table, then sit down and take questions and give answers.
imo
The company has already done a reverse split, it was many months ago, there was 125 million os they did a 5 to 1 reverse getting us back to 25 million os and a price share @ 2.00 dollars the stock was .40 @ the time, Nas wanted 1.00... after the split it could not hold... Fda was sitting on their hands to long for what they wanted... time ran out... back to bulletin board they have issued 25 some odd million shares to bring the os about 52 million now.
When they complete phase III and all fda requirements within the "phases" and the report is golden then the stock should be a strong one.
BUT
the new cfo has managed other companies by reversing their stock... it's the new stock structure I'm concerned about with this guy, if any of you get in the conference call, 'I can't have the time..' drill the hell out of them as to the structure of this if you like.
If all is managed well... this could be a mega huge one for this botanical type of hot flash drug and a super slingshot swing for the company.
Regards
Got my ipo shares, getting closer...'The Little Engine that Could'
Thanks all!
cheers
No,
but when can you sell of the earliest and still receive your dividend.
cheers
Hi,
new here, I have purchased sdvi shares. From what I have read and heard, could someone help clarify this:
The record date is the 15th of OCT, one should have the purchases in by and no later then the 12th of OCT so that all can be accounted for and recorded on/by the 15th.??
Also, can one dump all personal shares (sdvi) on the 16th of OCT and/or on the 15th, just before the close of the market bell, and still receive their dividends?
Any info would be appreciated,
cheers